Annual CFI:
-$228.65M-$134.40M(-142.60%)Summary
- As of today, VRDN annual cash from investing is -$228.65 million, with the most recent change of -$134.40 million (-142.60%) on December 31, 2024.
- During the last 3 years, VRDN annual cash from investing has fallen by -$154.36 million (-207.77%).
- VRDN annual cash from investing is now -910.07% below its all-time high of $28.23 million, reached on December 31, 2019.
Performance
VRDN Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFI:
$75.72M-$24.34M(-24.33%)Summary
- As of today, VRDN quarterly cash from investing is $75.72 million, with the most recent change of -$24.34 million (-24.33%) on June 30, 2025.
- Over the past year, VRDN quarterly cash from investing has increased by +$13.74 million (+22.17%).
- VRDN quarterly cash from investing is now -24.33% below its all-time high of $100.06 million, reached on March 31, 2025.
Performance
VRDN Quarterly Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
$28.20M+$13.74M(+95.06%)Summary
- As of today, VRDN TTM cash from investing is $28.20 million, with the most recent change of +$13.74 million (+95.06%) on June 30, 2025.
- Over the past year, VRDN TTM cash from investing has increased by +$230.94 million (+113.91%).
- VRDN TTM cash from investing is now -62.63% below its all-time high of $75.46 million, reached on September 30, 2023.
Performance
VRDN TTM Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
VRDN Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -142.6% | +22.2% | +113.9% |
| 3Y3 Years | -207.8% | +442.3% | +155.2% |
| 5Y5 Years | -910.1% | +100.0% | +215.1% |
VRDN Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -207.8% | at low | -24.3% | +144.6% | -62.6% | +108.4% |
| 5Y | 5-Year | -910.1% | at low | -24.3% | +144.6% | -62.6% | +108.4% |
| All-Time | All-Time | -910.1% | at low | -24.3% | +144.6% | -62.6% | +108.4% |
VRDN Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $75.72M(-24.3%) | $28.20M(+95.1%) |
| Mar 2025 | - | $100.06M(+259.0%) | $14.46M(+106.3%) |
| Dec 2024 | -$228.65M(-142.6%) | -$62.91M(+25.7%) | -$228.65M(+31.8%) |
| Sep 2024 | - | -$84.67M(-236.6%) | -$335.45M(-65.5%) |
| Jun 2024 | - | $61.98M(+143.3%) | -$202.74M(+9.5%) |
| Mar 2024 | - | -$143.04M(+15.7%) | -$224.00M(-137.7%) |
| Dec 2023 | -$94.25M(+18.1%) | -$169.71M(-453.3%) | -$94.25M(-224.9%) |
| Sep 2023 | - | $48.04M(+18.0%) | $75.46M(+175.2%) |
| Jun 2023 | - | $40.71M(+406.2%) | $27.42M(+4004.5%) |
| Mar 2023 | - | -$13.29M(-195.2%) | $668.00K(+101.3%) |
| Dec 2022 | -$115.13M(-55.0%) | - | - |
| Jun 2022 | - | $13.96M(+57.5%) | -$51.13M(+33.0%) |
| Mar 2022 | - | $8.86M(+111.0%) | -$76.30M(-2.7%) |
| Dec 2021 | -$74.29M(-47.2%) | -$80.21M(-1383.2%) | -$74.29M(-59.7%) |
| Sep 2021 | - | $6.25M(+155.8%) | -$46.51M(+11.9%) |
| Jun 2021 | - | -$11.21M(-203.1%) | -$52.81M(-26.9%) |
| Mar 2021 | - | $10.87M(+120.7%) | -$41.61M(+17.6%) |
| Dec 2020 | -$50.48M(-278.8%) | -$52.43M(>-9900.0%) | -$50.48M(-664.2%) |
| Sep 2020 | - | -$53.00K(>-9900.0%) | $8.95M(-55.3%) |
| Jun 2020 | - | $0.00(-100.0%) | $20.02M(-39.4%) |
| Mar 2020 | - | $2.00M(-71.4%) | $33.05M(+17.1%) |
| Dec 2019 | $28.23M | $7.00M(-36.5%) | $28.23M(-6.9%) |
| Sep 2019 | - | $11.02M(-15.4%) | $30.32M(+128.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | $13.03M(+561.9%) | $13.28M(+140.7%) |
| Mar 2019 | - | -$2.82M(-131.0%) | -$32.63M(-9.1%) |
| Dec 2018 | -$29.91M(-2992.4%) | $9.09M(+251.2%) | -$29.91M(+23.4%) |
| Sep 2018 | - | -$6.01M(+81.7%) | -$39.03M(-18.0%) |
| Jun 2018 | - | -$32.89M(>-9900.0%) | -$33.08M(>-9900.0%) |
| Mar 2018 | - | -$95.00K(-179.4%) | -$297.00K(-128.7%) |
| Dec 2017 | $1.03M(>+9900.0%) | -$34.00K(+46.0%) | $1.03M(-50.0%) |
| Sep 2017 | - | -$63.00K(+40.0%) | $2.07M(+133.9%) |
| Jun 2017 | - | -$105.00K(-108.5%) | $884.00K(-10.6%) |
| Mar 2017 | - | $1.24M(+23.6%) | $989.00K(+495.6%) |
| Dec 2016 | -$3000.00(+96.8%) | $1.00M(+180.2%) | -$250.00K(+79.6%) |
| Sep 2016 | - | -$1.25M(>-9900.0%) | -$1.22M(-6215.0%) |
| Jun 2016 | - | $0.00(+100.0%) | $20.00K(+600.0%) |
| Mar 2016 | - | -$3000.00(-111.1%) | -$4000.00(+91.1%) |
| Dec 2015 | -$95.00K(+65.3%) | $27.00K(+775.0%) | -$45.00K(+86.5%) |
| Sep 2015 | - | -$4000.00(+83.3%) | -$333.40K(+1.3%) |
| Jun 2015 | - | -$24.00K(+45.5%) | -$337.70K(-7.7%) |
| Mar 2015 | - | -$44.00K(+83.2%) | -$313.70K(-16.3%) |
| Dec 2014 | -$274.00K(-4666.7%) | -$261.40K(-3049.4%) | -$269.70K(-2374.3%) |
| Sep 2014 | - | -$8300.00(-219.2%) | -$10.90K(-319.2%) |
| Dec 2013 | $6000.00(+105.0%) | -$2600.00(-106.9%) | -$2600.00(-106.9%) |
| Dec 2012 | -$119.40K | - | - |
| Dec 2012 | - | $37.50K | $37.50K |
FAQ
- What is Viridian Therapeutics, Inc. annual cash from investing?
- What is the all-time high annual cash from investing for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. annual cash from investing year-on-year change?
- What is Viridian Therapeutics, Inc. quarterly cash from investing?
- What is the all-time high quarterly cash from investing for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. quarterly cash from investing year-on-year change?
- What is Viridian Therapeutics, Inc. TTM cash from investing?
- What is the all-time high TTM cash from investing for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. TTM cash from investing year-on-year change?
What is Viridian Therapeutics, Inc. annual cash from investing?
The current annual cash from investing of VRDN is -$228.65M
What is the all-time high annual cash from investing for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high annual cash from investing is $28.23M
What is Viridian Therapeutics, Inc. annual cash from investing year-on-year change?
Over the past year, VRDN annual cash from investing has changed by -$134.40M (-142.60%)
What is Viridian Therapeutics, Inc. quarterly cash from investing?
The current quarterly cash from investing of VRDN is $75.72M
What is the all-time high quarterly cash from investing for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high quarterly cash from investing is $100.06M
What is Viridian Therapeutics, Inc. quarterly cash from investing year-on-year change?
Over the past year, VRDN quarterly cash from investing has changed by +$13.74M (+22.17%)
What is Viridian Therapeutics, Inc. TTM cash from investing?
The current TTM cash from investing of VRDN is $28.20M
What is the all-time high TTM cash from investing for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high TTM cash from investing is $75.46M
What is Viridian Therapeutics, Inc. TTM cash from investing year-on-year change?
Over the past year, VRDN TTM cash from investing has changed by +$230.94M (+113.91%)